Evidence map›Paper›PMID 41625151›Full record

ArticleFrontiers in cellular and infection microbiology2025

Epidemiological and characteristic differences of hypervirulent and classical

Yushan Jiang, Nianqing Kong, Zhuolin Li, Weiling Wu, Yifei Xie, Zhujun Zeng, Tingting Peng, Chenguang Shen, Shi Ouyang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yushan JiangDepartment of Infectious Diseases, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Nianqing KongDepartment of Laboratory Medicine, Baiyun District People's Hospital of Guangzhou, Guangzhou, China.
Zhuolin LiBSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Weiling WuBSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Yifei XieDepartment of Infectious Diseases, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Zhujun ZengBSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Tingting PengDepartment of Infectious Diseases, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Chenguang ShenBSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
Shi OuyangDepartment of Infectious Diseases, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hypervirulent Method: A total of 97 non-duplicated Results: Among the 97 isolates, 40 (41.2%) were classified as hvKp. Compared with cKp, hvKp was significantly more likely to cause bacteraemia ( Discussion: The prevalence of hvKp increased during the COVID-19 pandemic in Guangdong, China. The isolates identified in this study represent sporadic infections, and the emergence of ST11-K64 hypervirulent carbapenem-resistant K. pneumoniae (hv-CRKp) highlights the urgent need for continued surveillance and vigilance regarding hvKp-associated bacteraemia.

Indexed as

COVID-19Klebsiella InfectionsKlebsiella pneumoniaeAgedAnti-Bacterial AgentsChinaFemaleGenome, BacterialHumansMaleMicrobial Sensitivity TestsMiddle AgedPandemicsSARS-CoV-2SerotypingVirulenceAnti-Bacterial Agentscommunity-acquired infectiondrug resistancehypervirulenceKlebsiella pneumoniaemultilocus sequence typing

Identifiers

PMID41625151
PMCPMC12855528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.